These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effect of chloramphenicol on human bone marrow]. Chyliński J Pol Tyg Lek; 1971 Apr; 26(17):650-1. PubMed ID: 4933493 [No Abstract] [Full Text] [Related]
4. Chloramphenicol-induced bone marrow suppression. Yunis AA Semin Hematol; 1973 Jul; 10(3):225-34. PubMed ID: 4577646 [No Abstract] [Full Text] [Related]
5. [Bone marrow damage caused by chloramphenicol]. Ruvidić R Srp Arh Celok Lek; 1969 May; 97(3):345-56. PubMed ID: 4908993 [No Abstract] [Full Text] [Related]
6. Chloramphenicol aplastic anemia in identical twins--a clue to pathogenesis. Dameshek W N Engl J Med; 1969 Jul; 281(1):42-3. PubMed ID: 5785735 [No Abstract] [Full Text] [Related]
7. Drug-induced bone marrow aplasia. Yunis AA Rev Bras Pesqui Med Biol; 1978 Oct; 11(4-5):287-95. PubMed ID: 725142 [No Abstract] [Full Text] [Related]
8. [Toxicity of chloramphenicol and thiamphenicol (CAP and TAP)]. Keiser G Haematol Blood Transfus; 1978; 21():179-95. PubMed ID: 367893 [No Abstract] [Full Text] [Related]
9. Why still prescribe chloramphenicol in 1983? Comparison of the clinical and biological hematologic effects of chloramphenicol and thiamphenicol. Baumelou E; Najean Y Blut; 1983 Dec; 47(6):317-20. PubMed ID: 6652243 [No Abstract] [Full Text] [Related]
11. Residual marrow damage: possible explanation for idiosyncrasy to chloramphenicol. Morley A; Trainor K; Remes J Br J Haematol; 1976 Apr; 32(4):525-31. PubMed ID: 1259934 [TBL] [Abstract][Full Text] [Related]
12. [Acquired panmyelopathies]. Keiser G Schweiz Med Wochenschr; 1970 Nov; 100(46):1938-48. PubMed ID: 5507832 [No Abstract] [Full Text] [Related]
13. [Hematologic side effects of chloramphenicol and thiamphenicol]. Keiser G; Bolli P; Buchegger U Schweiz Med Wochenschr; 1972 Nov; 102(44):1595-8. PubMed ID: 4645045 [No Abstract] [Full Text] [Related]
14. [Effects of chloramphenicol (CP) on in vitro colony-forming cell (CFU-C) in W anemic mice (author's transl)]. Kanamaru A; Kosaki M; Kai T; Kashitani Y; Nagai K Nihon Ketsueki Gakkai Zasshi; 1976 Dec; 39(6):815-20. PubMed ID: 1037460 [No Abstract] [Full Text] [Related]
15. Chloramphenicol toxicity: pathogenetic mechanisms and the role of the p-NO2 in aplastic anemia. Yunis AA; Miller AM; Salem Z; Arimura GK Clin Toxicol; 1980 Oct; 17(3):359-73. PubMed ID: 7004763 [No Abstract] [Full Text] [Related]
17. [Hepatitis-aplastic anemia syndrome (after the administration of chloramphenicol) (author's transl)]. Ito M; Fukuiya Y Rinsho Ketsueki; 1974 Sep; 15(9):985-92. PubMed ID: 4612200 [No Abstract] [Full Text] [Related]
18. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II. Chaplin S Adverse Drug React Acute Poisoning Rev; 1986; 5(3):181-96. PubMed ID: 3538824 [No Abstract] [Full Text] [Related]
19. [Pathology of pammyelophthisis following chloramphenicol administration (report of 18 cases)]. Flenker H; Remmele W Beitr Pathol; 1972; 145(1):8-23. PubMed ID: 5014745 [No Abstract] [Full Text] [Related]
20. [Four additional cases of aplastic anemia following chloramphenicol therapy]. Speck B; Moeschlin S Schweiz Med Wochenschr; 1969 Jun; 99(25):910-4. PubMed ID: 4241791 [No Abstract] [Full Text] [Related] [Next] [New Search]